Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

An overview of PET neuroimaging.

Nasrallah I, Dubroff J.

Semin Nucl Med. 2013 Nov;43(6):449-61. doi: 10.1053/j.semnuclmed.2013.06.003. Review.

PMID:
24094712
2.

PET approaches for diagnosis of dementia.

Ishii K.

AJNR Am J Neuroradiol. 2014 Nov-Dec;35(11):2030-8. doi: 10.3174/ajnr.A3695. Epub 2013 Aug 14. Review.

3.

Positron emission tomography imaging in dementia.

Herholz K, Carter SF, Jones M.

Br J Radiol. 2007 Dec;80 Spec No 2:S160-7. doi: 10.1259/bjr/97295129. Review.

PMID:
18445746
4.

Neuronuclear assessment of patients with epilepsy.

Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W.

Semin Nucl Med. 2008 Jul;38(4):227-39. doi: 10.1053/j.semnuclmed.2008.02.004. Review.

PMID:
18514079
5.

Target-specific PET probes for neurodegenerative disorders related to dementia.

Kadir A, Nordberg A.

J Nucl Med. 2010 Sep;51(9):1418-30. doi: 10.2967/jnumed.110.077164. Review.

6.

Molecular neuroimaging in degenerative dementias.

Jiménez Bonilla JF, Carril Carril JM.

Rev Esp Med Nucl Imagen Mol. 2013 Sep-Oct;32(5):301-9. doi: 10.1016/j.remn.2013.06.012. Epub 2013 Aug 9. Review. English, Spanish.

7.

Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.

Mitsis EM, Riggio S, Kostakoglu L, Dickstein DL, Machac J, Delman B, Goldstein M, Jennings D, D'Antonio E, Martin J, Naidich TP, Aloysi A, Fernandez C, Seibyl J, DeKosky ST, Elder GA, Marek K, Gordon W, Hof PR, Sano M, Gandy S.

Transl Psychiatry. 2014 Sep 16;4:e441. doi: 10.1038/tp.2014.91.

8.

Brain FDG PET and the diagnosis of dementia.

Shivamurthy VK, Tahari AK, Marcus C, Subramaniam RM.

AJR Am J Roentgenol. 2015 Jan;204(1):W76-85. doi: 10.2214/AJR.13.12363. Review.

PMID:
25539279
9.

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.

Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.

Neuroimage. 2008 Jan 15;39(2):619-33. Epub 2007 Sep 21.

PMID:
17962045
10.

Use of florbetapir-PET for imaging beta-amyloid pathology.

Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, Sabbagh MN, Sadowsky CH, Reiman EP, Zehntner SP, Skovronsky DM; AV45-A07 Study Group.

JAMA. 2011 Jan 19;305(3):275-83. doi: 10.1001/jama.2010.2008. Erratum in: JAMA. 2011 Mar 16;305(11):1096. Reiman, P Eric M [corrected to Reiman, Eric M].

PMID:
21245183
11.

Molecular imaging of dementia.

Mori T, Maeda J, Shimada H, Higuchi M, Shinotoh H, Ueno S, Suhara T.

Psychogeriatrics. 2012 Jun;12(2):106-14. doi: 10.1111/j.1479-8301.2012.00409.x. Review.

12.

Guidance for reading FDG PET scans in dementia patients.

Herholz K.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):332-43. Epub 2014 Nov 13. Review.

13.

Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.

Nasrallah IM, Wolk DA.

J Nucl Med. 2014 Dec;55(12):2003-11. doi: 10.2967/jnumed.114.141416. Epub 2014 Nov 20. Review.

14.

Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting.

Banzo I, Jiménez-Bonilla J, Ortega-Nava F, Quirce R, Martínez-Rodríguez I, de Arcocha-Torres M, Rodríguez E, Vázquez JL, Sánchez PJ, Martínez-Amador N, Ibañez-Bravo S, Carril JM.

Nucl Med Commun. 2014 Mar;35(3):238-44. doi: 10.1097/MNM.0000000000000042.

PMID:
24240196
15.

Positron emission tomography in presurgical localization of epileptic foci.

Csaba J.

Ideggyogy Sz. 2003 Jul 20;56(7-8):249-54.

PMID:
12971120
16.

PET radiotracers for molecular imaging in dementia.

Baskin A, Giannakopoulos P, Ratib O, Seimbille Y, Assal F, Perani D, Garibotto V.

Curr Radiopharm. 2013 Dec;6(4):215-30. Review.

PMID:
24283962
17.

Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia.

Eisenmenger LB, Huo EJ, Hoffman JM, Minoshima S, Matesan MC, Lewis DH, Lopresti BJ, Mathis CA, Okonkwo DO, Mountz JM.

Semin Nucl Med. 2016 Jan;46(1):57-87. doi: 10.1053/j.semnuclmed.2015.09.003. Review.

PMID:
26687858
18.

Three presenile patients in which neuropsychological and neuroimaging examinations suggest possible progression to dementia with Lewy bodies.

Ota K, Iseki E, Murayama N, Chiba Y, Fujishiro H, Kasanuki K, Manabe Y, Arai H, Sato K.

Psychogeriatrics. 2014 Mar;14(1):72-80. doi: 10.1111/psyg.12039. Epub 2014 Feb 16.

19.

Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.

Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, Becker G, Möller HE, Villringer A, Sabri O, Schroeter ML.

Neuroimage. 2010 Jan 15;49(2):1490-5. doi: 10.1016/j.neuroimage.2009.09.017. Epub 2009 Sep 18.

PMID:
19770055
20.

18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.

Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, Kang E, Na DL, Kim SE.

J Nucl Med. 2005 Feb;46(2):233-9.

Supplemental Content

Support Center